Universal Diagnostics SL news
2021 Cohort to Prominently Feature the Industry’s Best and Brightest Startups Working to Transform Patient Care Through Innovation
LOS ANGELES — June 15, 2021 — MedTech Innovator, the largest accelerator of medical device companies in the world, today announced the 50 companies selected to participate in the organization’s flagship four-month Showcase and
New results from the OMICS study, the company`s prospective, international, multi-center study, show Universal DX`s blood test can detect colorectal advanced adenomas at 55% sensitivity and 90% specificity, which exceeds currently available non-invasive tests for colorectal cancer screening
80% of sporadic colorectal cancers arise from pre-malignant advanced adenomas, making early detection critical to saving lives
(JUNE 9, 2021) CAMBRIDGE, MA. - Universal Dia
New results from the OMICS study, which will be presented atASCO, show Universal DX`s blood test can detect colorectal cancer with extraordinary accuracy (92% sensitivity / 97% specificity), which exceeds currently available non-invasive tests for colorectal cancer screening
Early detection cancer screening via a liquid biopsy is not only critical to save lives, but is a vast market opportunity, ranging between S30B and S75B in the U.S. alone
(JUNE 3, 2021) CAMBRIDGE,